These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38398377)

  • 21. [Maternal morbidity and mortality associated with conservative management for placenta morbidly adherent (accreta) diagnosed during pregnancy. Report of 15 cases].
    Daney de Marcillac F; Lecointre L; Guillaume A; Sananes N; Fritz G; Viville B; Boudier E; Nisand I; Gaudineau A; Langer B; Akladios CY
    J Gynecol Obstet Biol Reprod (Paris); 2016 Oct; 45(8):849-858. PubMed ID: 27118678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum.
    Zuckerwise LC; Craig AM; Newton JM; Zhao S; Bennett KA; Crispens MA
    Am J Obstet Gynecol; 2020 Feb; 222(2):179.e1-179.e9. PubMed ID: 31469990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders: systematic review and meta-analysis.
    Lucidi A; Jauniaux E; Hussein AM; Coutinho CM; Tinari S; Khalil A; Shamshirsaz A; Palacios-Jaraquemada JM; D'Antonio F
    Ultrasound Obstet Gynecol; 2023 Nov; 62(5):633-643. PubMed ID: 37401769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): A multinational database study.
    Schwickert A; van Beekhuizen HJ; Bertholdt C; Fox KA; Kayem G; Morel O; Rijken MJ; Stefanovic V; Strindfors G; Weichert A; Weizsaecker K; Braun T;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1():29-40. PubMed ID: 33524163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical Management of the Placenta Accreta Spectrum: An Institutional Experience.
    Mitric C; Desilets J; Balayla J; Ziegler C
    J Obstet Gynaecol Can; 2019 Nov; 41(11):1551-1557. PubMed ID: 30948337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of placenta previa attached to cesarean scar for adverse pregnant outcomes in patients with placenta accreta spectrum disorders].
    Zheng WR; Yang XR; Sun J; Mu Y; Yan J; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Dec; 56(12):861-867. PubMed ID: 34954965
    [No Abstract]   [Full Text] [Related]  

  • 27. Prophylactic intraoperative uterine artery embolization to control hemorrhage in abnormal placentation during late gestation.
    Yu PC; Ou HY; Tsang LL; Kung FT; Hsu TY; Cheng YF
    Fertil Steril; 2009 May; 91(5):1951-5. PubMed ID: 18501901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uterine conservation in placenta accrete spectrum (PAS) disorders: A retrospective case series: Is expectant management beneficial in reducing maternal morbidity?
    Lional KM; Tagore S; Wright AM
    Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():212-217. PubMed ID: 33011503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study.
    Sentilhes L; Seco A; Azria E; Beucher G; Bonnet MP; Branger B; Carbillon L; Chiesa C; Crenn-Hebert C; Dreyfus M; Dupont C; Fresson J; Huissoud C; Langer B; Morel O; Patrier S; Perrotin F; Raynal P; Rozenberg P; Rudigoz RC; Vendittelli F; Winer N; Deneux-Tharaux C; Kayem G;
    Am J Obstet Gynecol; 2022 Jun; 226(6):839.e1-839.e24. PubMed ID: 34914894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Outcome analysis of pregnancy termination and expectant treatment in pregnant women with suspected invasive placenta accreta spectrum disorders in the second trimester].
    Chen L; Wang Y; Liang SY; Shi HF; Zhao YY
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jul; 58(7):489-494. PubMed ID: 37474321
    [No Abstract]   [Full Text] [Related]  

  • 31. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study.
    Fitzpatrick KE; Sellers S; Spark P; Kurinczuk JJ; Brocklehurst P; Knight M
    BJOG; 2014 Jan; 121(1):62-70; discussion 70-1. PubMed ID: 23924326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of distal haemostasis during caesarean delivery in women with placenta accreta spectrum disorders.
    Barinov SV; Shmakov RG; Medyannikova IV; Tirskaya YI; Kadtsyna TV; Lazareva OV; Razdobedina IN; Neustroyeva TN; Stepanov SS
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8778-8785. PubMed ID: 34794371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic Uterine Artery Embolization in Placenta Accreta Spectrum-An Active Intervention to Reduce Morbidity and Promote Uterine Preservation.
    Sebastian B; Rajesh U; Scott PM; Sayeed S; Robinson GJ; Ettles DF; Shrivastava V; Lakshminarayan R
    J Vasc Interv Radiol; 2023 Nov; 34(11):1922-1928. PubMed ID: 37517463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caesarean section combined with temporary aortic balloon occlusion followed by uterine artery embolisation for the management of placenta accreta.
    Duan XH; Wang YL; Han XW; Chen ZM; Chu QJ; Wang L; Hai DD
    Clin Radiol; 2015 Sep; 70(9):932-7. PubMed ID: 25937242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective analysis of obstetric and anesthetic management of patients with placenta accreta spectrum disorders.
    Riveros-Perez E; Wood C
    Int J Gynaecol Obstet; 2018 Mar; 140(3):370-374. PubMed ID: 29080306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The multidisciplinary management of placenta accreta spectrum (PAS) within a single tertiary centre: A ten-year experience.
    Yasin N; Slade L; Atkinson E; Kennedy-Andrews S; Scroggs S; Grivell R
    Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):550-554. PubMed ID: 30565213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Open versus endovascular REBOA control of blood loss during cesarean delivery in the placenta accreta spectrum: A single-center retrospective case control study.
    Riazanova OV; Reva VA; Fox KA; Romanova LA; Kulemin ES; Riazanov AD; Ioscovich A
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():23-28. PubMed ID: 33388487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of emergency Cesarean delivery in pregnancies complicated by placenta previa with or without placenta accreta spectrum disorder: analysis of ADoPAD cohort.
    ADoPAD (Antenatal Diagnosis of Placental Attachment Disorders) Study Group
    Ultrasound Obstet Gynecol; 2024 Feb; 63(2):243-250. PubMed ID: 37698306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified one-step conservative uterine surgery (MOSCUS) versus cesarean hysterectomy in the management of placenta accreta spectrum: A single-center retrospective analysis based on 619 Vietnamese pregnant women.
    Vuong ADB; Pham TH; Pham XTT; Truong DP; Nguyen XT; Trinh NB; Nguyen DV; Nguyen YON; Nguyen TNTN; Ho QN; Nguyen PN
    Int J Gynaecol Obstet; 2024 May; 165(2):723-736. PubMed ID: 38009657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter observational survey of management strategies in 442 pregnancies with suspected placenta accreta spectrum.
    van Beekhuizen HJ; Stefanovic V; Schwickert A; Henrich W; Fox KA; MHallem Gziri M; Sentilhes L; Gronbeck L; Chantraine F; Morel O; Bertholdt C; Braun T; Rijken MJ; Duvekot JJ;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1(Suppl 1):12-20. PubMed ID: 33483943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.